BioGrowth company plans to produce coenzyme Q10 From sugar cane in Brazil. According to the company statement, the company has been working on the project, which has been financed with private resources, since May this year.
Using bacterial fermentation techniques, the new technology aims to meet the demands of the domestic market, which is currently dependent on imports.
basis for the functioning cellsThis substance is produced naturally by the body, but some people need supplements due to certain health conditions.
Patients with heart or muscle problems and even some physical activity practitioners regularly consume coenzymes. Currently, the country imports the substance from abroad due to lack of technology.
The new production facility is an initiative that can reduce the dependency on the national foreign market and lower the price of the product. It will also use sugarcane, which is widely grown in Brazil, as a source.
According to the company statement, the research was conducted and financed entirely by private funds raised in partnership with Hurst Capital, in an operation called equity crowdfunding that attracts funds from private investors.
In Brazil, scientific research is almost entirely funded by the state. Hurst CEO Arthur Farache said in a statement that the company plans to invest in future projects that are economically viable and promote financial returns.
Source: Tec Mundo
I am Bret Jackson, a professional journalist and author for Gadget Onus, where I specialize in writing about the gaming industry. With over 6 years of experience in my field, I have built up an extensive portfolio that ranges from reviews to interviews with top figures within the industry. My work has been featured on various news sites, providing readers with insightful analysis regarding the current state of gaming culture.
